Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

The DEAD-Box RNA Helicase DDX3 Interacts with NF-κB Subunit p65 and Suppresses p65-Mediated Transcription.

Xiang N, He M, Ishaq M, Gao Y, Song F, Guo L, Ma L, Sun G, Liu D, Guo D, Chen Y.

PLoS One. 2016 Oct 13;11(10):e0164471. doi: 10.1371/journal.pone.0164471.

2.

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

Buckley NE, Haddock P, De Matos Simoes R, Parkes E, Irwin G, Emmert-Streib F, McQuaid S, Kennedy R, Mullan P.

Oncotarget. 2016 Apr 12;7(15):19884-96. doi: 10.18632/oncotarget.7865.

3.
4.

Interplay of Rad51 with NF-κB pathway stimulates expression of HIV-1.

Kaminski R, Wollebo HS, Datta PK, White MK, Amini S, Khalili K.

PLoS One. 2014 May 21;9(5):e98304. doi: 10.1371/journal.pone.0098304.

5.

BRCA1 and Oxidative Stress.

Yi YW, Kang HJ, Bae I.

Cancers (Basel). 2014 Apr 3;6(2):771-95. doi: 10.3390/cancers6020771.

6.

Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation.

Gardini A, Baillat D, Cesaroni M, Shiekhattar R.

EMBO J. 2014 Apr 16;33(8):890-905. doi: 10.1002/embj.201385567. Erratum in: EMBO J. 2014 Sep 17;33(18):2134.

7.

NF-κB is a critical mediator of BRCA1-induced chemoresistance.

Harte MT, Gorski JJ, Savage KI, Purcell JW, Barros EM, Burn PM, McFarlane C, Mullan PB, Kennedy RD, Perkins ND, Harkin DP.

Oncogene. 2014 Feb 6;33(6):713-23. doi: 10.1038/onc.2013.10.

8.

Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma.

Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS.

Oncogene. 2013 Oct 24;32(43):5144-55. doi: 10.1038/onc.2012.546.

9.

NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes.

Volcic M, Karl S, Baumann B, Salles D, Daniel P, Fulda S, Wiesmüller L.

Nucleic Acids Res. 2012 Jan;40(1):181-95. doi: 10.1093/nar/gkr687.

10.

Pathway-based analysis using reduced gene subsets in genome-wide association studies.

Zhao J, Gupta S, Seielstad M, Liu J, Thalamuthu A.

BMC Bioinformatics. 2011 Jan 12;12:17. doi: 10.1186/1471-2105-12-17.

11.

NF-κB addiction and its role in cancer: 'one size does not fit all'.

Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB.

Oncogene. 2011 Apr 7;30(14):1615-30. doi: 10.1038/onc.2010.566. Review.

12.

BRCA1 represses amphiregulin gene expression.

Lamber EP, Horwitz AA, Parvin JD.

Cancer Res. 2010 Feb 1;70(3):996-1005. doi: 10.1158/0008-5472.CAN-09-2842.

13.

Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis.

Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, Garcia MJ, Caldés T, Blanco I, Gariboldi M, Pierotti MA, Pujana MA, Benítez J, Osorio A.

Br J Cancer. 2009 Oct 20;101(8):1469-80. doi: 10.1038/sj.bjc.6605275.

14.

A novel mechanism of nuclear factor-kappaB regulation by adenoviral protein 14.7K.

Carmody RJ, Maguschak K, Chen YH.

Immunology. 2006 Feb;117(2):188-95.

15.

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Luo JL, Kamata H, Karin M.

J Clin Invest. 2005 Oct;115(10):2625-32. Review.

Supplemental Content

Support Center